Today's Daily Dose brings you news about Seres Therapeutics' ECOSPOR trial data, acquisition of Pfenex by Ligand, Trevena's pain drug getting FDA nod, Reata update on investigational drug Omaveloxolone being developed for Friedreich's Ataxia, and disappointing results from Catalyst Pharma's MuSK-MG trial, among others.
from RTT - Biotech https://ift.tt/30KLoLt
via IFTTT
No comments:
Post a Comment